Table 2.

Patients, interventions and complications’ description.

Patient description	Intervention	MMR inclusion criteria
F 46, PS1 ASA1 Appendicular peritoneal pseudomyxoma	Complete cytoreduction + hyperthermic intraperitoneal chemotherapy	Wernicke's encephalopathy POD42; CD5.
M 52, PS1 ASA 1 Adenocarcinoma of the splenic colic flexure	Left colectomy extended to the stomach and caudal pancreas	Profuse haematemesis at POD17; CD5
M 75, PS2 ASA 1 Rectal adenocarcinoma	Partial mesorectal excision + colostomy	Pelvic collection, hyperkalemia, pneumopathy; CD 4a
M 51, PS1 ASA1 Malignant degeneration of colorectal polyposis	Coloproctectomy + ileo rectal anastomosis	Postoperative peritonitis POD18; CD3b
F 60, PS2 ASA1 Obstructive left colon adenocarcinoma	Left colectomy + colo-colic anastomosis	Postoperative peritonitis POD4; CD3b
M 46, PS1 ASA1 Adenocarcinoma of the ascending colon	Right colectomy + end to side ileocolic anastomosis iliac lymphadenectomy	Postoperative abdominal abscess at POD6; CD3b
M 60, PS1 ASA1 Rectal adenocarcinoma	Total mesorectal excision + delayed colo anal anastomosis	Anastomotic leak + pelvic abscess at POD 15; CD3b
M 55, PS1 ASA2 Hepatocellular carcinoma	Segment 5 hepatectomy	Decompensated cirrhosis (hemorrhage) at POD3. CD5
M 63, PS1 ASA1 Rectal adenocarcinoma	Total mesorectal excision + delayed colo anal anastomosis	Pelvic collection at POD14. CD3b
M 53, PS1 ASA1 Esophageal adenocarcinoma	Lewis-Santy esophagectomy mecanic end to side anastomosis	Pneumopathy POD4. CD4a

PS = Physical Status score ASA = American Society of Anesthesiologists score, F = female, M = male, CD= Clavien Dindo score, POD = post operative day.